Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge. - Wikidata - wikimedia - TriplyDB

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.

http://www.wikidata.org/entity/Q33804531

about

Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines.Systems serology: profiling vaccine induced humoral immunity against HIV.Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations.An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies.Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective Outcome.A trimeric HIV-1 envelope gp120 immunogen induces potent and broad anti-V1V2 loop antibodies against HIV-1 in rabbits and rhesus macaques.Prospects from systems serology research.Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques.HIV-1 specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galcer Blocking and Phagocytosis.Haiku: New paradigm for the reverse genetics of emerging RNA viruses.Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates.Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV.Advances in HIV-1 Vaccine Development.Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors.Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay.High-resolution definition of humoral immune response correlates of effective immunity against HIV.Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses.Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies

P2860

Q41933070-D0CBE948-BF4D-482B-A347-924094675974 Q47104983-868E8A18-DE4C-4A12-9DDA-699964B066FC Q47118310-CADEC6FF-1A2A-4583-977E-214AA76C20B4 Q47150417-314A28F9-F3E1-4E33-97F6-ED162C870E74 Q47218587-566203A4-B611-4DFD-A851-C272E1B19077 Q47296227-5112EB46-CE07-4BC9-96F9-BBA7983C78E3 Q47346211-7F98B384-0BDF-4608-9D73-EDB238E9A654 Q47550072-CEDBBC5A-4AC8-49D2-9F3F-FFF1B513A627 Q47555844-F64F1B65-B47C-40A7-BEAB-01FD58BB52E4 Q50041776-28C98AE8-DDD9-40B2-AE33-111AA218B68C Q50043326-E7BF51B3-D5F8-46E8-82C4-EA4737056A02 Q50209602-7D279541-0F89-451B-A2BB-BEA9EDA3A3C3 Q52609661-1258E86F-00C6-462B-B41E-B373A1858224 Q53692345-881F20A0-0E5E-4838-BAED-302BC00ED2F7 Q54233000-D01D5C45-F565-4015-B493-9611CB0E359C Q54263363-EAF9B5B3-B58D-4B33-9D50-F675A6F1413A Q55022148-FC5506B9-E8D1-4776-9CA5-EFCFACA08230 Q55411165-688296A6-917D-4B84-8541-1B05563479DB Q56995988-E050D8C5-71E8-407D-80E6-BD4A0EE887EF Q58606356-B2816216-EE0E-44CE-ABCC-A8161491C813

P2860

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.

http://www.wikidata.org/entity/Q33804531

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.

@ast

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.

@en

type

label

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.

@ast

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.

@en

prefLabel

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.

@ast

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.

@en

P1433

Q33804531-B195E1C6-2BA7-4A84-9BDE-4B7072642517

P1476

Q33804531-CC77D4B9-F294-407F-9319-CA36B31ADFA3

P2093

Q33804531-09A36921-1EF5-4D30-AD02-4EEAC5A61E9D

Q33804531-1390AC61-C421-4398-8428-DA32532D3308

Q33804531-1F1A13AE-BFF3-4795-A90D-67749FB8E995

Q33804531-22BE4370-6873-4EA3-9507-29AC39C3F8CE

Q33804531-24A0076B-0845-4B9C-9E0F-8B00705506BD

Q33804531-30348925-44AA-4F90-9714-182E36C5B909

Q33804531-3CA5073F-5871-4B1A-91A4-D8A101DEE999

Q33804531-3E5DD8FE-3B15-4069-9CF7-90B314503EC5

Q33804531-482FC0E1-6F97-4A68-B157-4B76652B0DD7

Q33804531-494F1D34-F90A-4634-81DD-215F3AAD0242

P2860

Q33804531-01AF3B1F-6BA7-4808-8F60-3405F4D74A76

Q33804531-0243B9F9-9D19-4E91-B5BC-EC9EB3B5F76A

Q33804531-0E04858B-0379-4361-924A-BBA6B7BACCA0

Q33804531-0FCEE559-56AE-4A1A-A9FF-72BB953999E3

Q33804531-13400A6A-95B1-4272-88CE-23B67805414A

Q33804531-141086CA-D1A6-4581-86F0-2A750788E1DE

Q33804531-1436EAEF-7545-4AD3-989A-0C6F78E09DE1

Q33804531-1D21B145-0007-4749-ACDF-0C6E8B75C73B

Q33804531-23FE9204-C49C-4A3D-B97D-B7D478364486

Q33804531-28D2FCC9-3534-4201-A81F-4CDFB9C61A09

P2888

Q33804531-97B9374B-30BD-41F4-9328-B50F15A4E312

P304

Q33804531-86E94C62-15D9-47C6-B839-23B42EA80A9D

P31

Q33804531-E3A3CB7A-10AD-4BA6-A432-2C6C9A4E3DC1

P356

Q33804531-9EBC0B56-5393-4E04-9327-86B7CF55FF8B

P407

Q33804531-C2AD81DD-A09C-4430-A6AC-8AE00D0662FD

P478

Q33804531-C4961F89-EDF6-46F1-B56C-7C637C36A20C

P50

Q33804531-07BB0C7F-C95F-40DA-9603-DED3CE2DA2E7

Q33804531-416C13DD-4D7D-42EB-82F7-5ECC30E68D31

Q33804531-4C345D8D-ADD8-454C-A3CA-5E833D07151B

Q33804531-B3502D05-0DBE-468C-B339-FE3022C3DD23

Q33804531-D3462BF7-9B9E-4206-A31D-63A000F96899

Q33804531-E9BE99CE-7CA7-4553-ABF9-67940908DCE0

P577

Q33804531-E836CF2F-006C-434F-9EC8-30AF2A71C397

P6179

Q33804531-1EAFAF41-CD20-433E-AEA0-B337BD898DA7

P698

Q33804531-4D26DE93-720B-4A3D-9DD7-FAE422030749

P932

Q33804531-6713F9F6-C631-45D6-A759-ECC9E13EC6AA

P356

P1433

Nature Communications

P1476

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.

@en

P2093

Abraham Pinter

http://www.w3.org/2001/XMLSchema#string

Amanda Eaton

http://www.w3.org/2001/XMLSchema#string

Bette T Korber

http://www.w3.org/2001/XMLSchema#string

Chris Bailey-Kellogg

http://www.w3.org/2001/XMLSchema#string

Derrick Goodman

http://www.w3.org/2001/XMLSchema#string

Galit Alter

http://www.w3.org/2001/XMLSchema#string

Harikrishnan Balachandran

http://www.w3.org/2001/XMLSchema#string

Hua-Xin Liao

http://www.w3.org/2001/XMLSchema#string

James F Theis

http://www.w3.org/2001/XMLSchema#string

Jim Tartaglia

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells

Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals

Antibody responses to envelope glycoproteins in HIV-1 infection

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

Progress in HIV-1 vaccine development.

New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0

High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses

P2888

P304

15711

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS15711

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

David C Montefiori

Georgia Tomaras

P577

2017-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085927536

http://www.w3.org/2001/XMLSchema#string

P698

28593989

http://www.w3.org/2001/XMLSchema#string

P932

5472724

http://www.w3.org/2001/XMLSchema#string